Historically, these associations between genetics and AD have been thought to be the consequences of toxic oligomer and amyloid fibril formation by Aβ polypeptides released after successive proteolysis of APP by the β- and γ-secretase proteases (Fig. 1A) (7, 11, 12). This evidence concerns the gene APP and Alzheimer disease.